Sort   by:  
 Page size 
UnknownResults of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria.
Not available
S-EPMC10435727 | biostudies-literature
UnknownIL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation.
Not available
S-EPMC8304527 | biostudies-literature
UnknownDefining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT.
Not available
S-EPMC8605455 | biostudies-literature
UnknownChimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia.
Not available
S-EPMC6746038 | biostudies-literature
UnknownPreclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma.
Not available
S-EPMC7776337 | biostudies-literature
UnknownImpact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors.
Not available
S-EPMC3012773 | biostudies-literature
UnknownGenetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells∗
Not available
S-EPMC11847098 | biostudies-literature
UnknownAt-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program.
Not available
S-EPMC10748136 | biostudies-literature
UnknownT-cell responses against CD19-targeted CAR T cells varnimcabtagene autoleucel (ARI-0001): implications for immune response and therapy outcomes.
Not available
S-EPMC12458724 | biostudies-literature
UnknownLong-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.
Not available
S-EPMC3744747 | biostudies-literature
Sort   by:  
 Page size